Delivery Order SPE2DB22D9239-SPE2DB25FDM13
- Not listed
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Cerdelga 84 mg capsules. The $30,046.61 order calls for 14 units of the medication to be delivered to a facility in Park Ridge, Illinois by November 17, 2023. DMS Pharmaceutical Group holds this pharmaceutical prime vendor contract with the Defense Logistics Agency to directly supply prescription medications and services to support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,185.93 firm fixed-price contract is for the delivery of 4566706859 Cerdelga 84 mg capsules. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $32,185.93 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 84mg capsules of the pharmaceutical product CERDELGA. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $32,185.93 for Cerdelga 84 mg capsules (14-count packages). This firm fixed-price delivery order, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a specific product fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The company was...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $231,827.60 by the Defense Logistics Agency's Medical Supply Chain division on August 12, 2025, with an ultimate completion date of August 13, 2025. This delivery order was issued without set-aside designation and represents a specific pharmaceutical product delivery executed under the company's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $33,614.64 by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a continuation of services under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $32,185.93 contract is for the delivery of CERDELGA 84 MG CAPSULE 14S, a pharmaceutical product. The order has an ultimate completion date of August 7, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $34,908 on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This delivery order, which is expected to be completed by August 28, 2025, represents a continuation of supply under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $73,952.48 by the Defense Logistics Agency's Medical Supply Chain division on March 5, 2025, with an ultimate completion date of March 10, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a task order issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $194,999.40 firm fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, with an ultimate completion date of August 14, 2025. This delivery order was issued without a set-aside designation and represents a specific purchase under the company's larger Indefinite Delivery Contract with the DLA valued at $499,999,999...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDM13Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $21,891.08 by the Defense Logistics Agency on September 22, 2025, for the supply of Cerdelga 84 mg capsules (quantity: 14 units). This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, carries no set-aside designation and represents work performed under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of delivery orders to the Defense Logistics Agency covering an extensive range of pharmaceutical products including prescription medications, biologics, and medical consumables serving Department of Defense healthcare facilities nationwide. The company's federal contracting history demonstrates consistent success in securing orders without set-aside restrictions, leveraging its woman-owned small business status to compete effectively in government procurement markets while maintaining SAM.gov registration since 2001.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.9k | 9/22/25 |